Influence of Erroneous Patient Records on Population Pharmacokinetic Modeling and Individual Bayesian Estimation

被引:9
|
作者
van der Meer, Aize Franciscus [1 ]
Touw, Daniel J. [2 ]
Marcus, Marco A. E. [1 ]
Neef, Cornelis [3 ]
Proost, Johannes H. [4 ]
机构
[1] Maastricht Univ, Med Ctr, Dept Anesthesiol, NL-6202 AZ Maastricht, Netherlands
[2] Cent Hosp Pharm, The Hague, Netherlands
[3] Maastricht Univ, Med Ctr, Dept Clin Pharm, NL-6202 AZ Maastricht, Netherlands
[4] Univ Groningen, Univ Ctr Pharm, Dept Pharmacokinet Toxicol & Targeting, Groningen, Netherlands
关键词
maximum a posteriori Bayesian estimation; pharmacokinetics; population modeling; patient records; error identification; PERFORMANCE; VANCOMYCIN; SIMULATION;
D O I
10.1097/FTD.0b013e3182616937
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Observational data sets can be used for population pharmacokinetic (PK) modeling. However, these data sets are generally less precisely recorded than experimental data sets. This article aims to investigate the influence of erroneous records on population PK modeling and individual maximum a posteriori Bayesian (MAPB) estimation. Methods: A total of 1123 patient records of neonates who were administered vancomycin were used for population PK modeling by iterative 2-stage Bayesian (ITSB) analysis. Cut-off values for weighted residuals were tested for exclusion of records from the analysis. A simulation study was performed to assess the influence of erroneous records on population modeling and individual MAPB estimation. Also the cut-off values for weighted residuals were tested in the simulation study. Results: Errors in registration have limited the influence on outcomes of population PK modeling but can have detrimental effects on individual MAPB estimation. A population PK model created from a data set with many registration errors has little influence on subsequent MAPB estimates for precisely recorded data. A weighted residual value of 2 for concentration measurements has good discriminative power for identification of erroneous records. Conclusions: ITSB analysis and its individual estimates are hardly affected by most registration errors. Large registration errors can be detected by weighted residuals of concentration.
引用
收藏
页码:526 / 534
页数:9
相关论文
共 50 条
  • [1] The Bayesian modeling of covariates for population pharmacokinetic models
    Wakefield, J
    Bennett, J
    JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1996, 91 (435) : 917 - 927
  • [2] Vancomycin population pharmacokinetic modeling in children using Bayesian estimation and a Non Parametric Approach
    Oliveira Silveira, Anna Luisa
    da Silva Alves, Geisa Cristina
    Xie, Jiao
    Roberts, Jason A.
    Sanches, Cristina
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 58
  • [3] THE HIERARCHICAL BAYESIAN-APPROACH TO POPULATION PHARMACOKINETIC MODELING
    SMITH, A
    WAKEFIELD, J
    INTERNATIONAL JOURNAL OF BIO-MEDICAL COMPUTING, 1994, 36 (1-2): : 35 - 42
  • [4] A Bayesian formulation of the Kalman filter applied to the estimation of individual pharmacokinetic parameters
    Botsman, K
    Tickle, K
    Smith, JD
    COMPUTERS AND BIOMEDICAL RESEARCH, 1997, 30 (02): : 83 - 94
  • [5] Voriconazole clearance estimation using pharmacokinetic population modeling
    Metsu, D.
    Lamoureux, F.
    Laffont, M. A.
    Seraissol, P.
    Marquet, P.
    Gandia, P.
    Woillard, J. B.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 : 64 - 65
  • [6] Population Pharmacokinetic Modeling and Optimal Sampling Strategy for Bayesian Estimation of Amikacin Exposure in Critically Ill Septic Patients
    Delattre, Isabelle K.
    Musuamba, Flora T.
    Nyberg, Joakim
    Taccone, Fabio S.
    Laterre, Pierre-Francois
    Verbeeck, Roger K.
    Jacobs, Frederique
    Wallemacq, Pierre E.
    THERAPEUTIC DRUG MONITORING, 2010, 32 (06) : 749 - 756
  • [7] A SEQUENTIAL METHOD FOR ESTIMATION OF POPULATION PHARMACOKINETIC PARAMETERS ON A PATIENT BY PATIENT BASIS
    SCHUMITZKY, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (02) : 227 - 227
  • [8] Population pharmacokinetic modeling of gentamicin in neonates - A comparison with Bayesian methods.
    Ariano, RE
    Sitar, DS
    Zelenitsky, SA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P84 - P84
  • [9] Bayesian Population Pharmacokinetic Modeling of Eltrombopag in Chronic Hepatitis C Patients
    Mohammad I. Saleh
    Suhad Bani Melhim
    Hanguin M. Al-Ramadhani
    Sameh Alzubiedi
    European Journal of Drug Metabolism and Pharmacokinetics, 2019, 44 : 31 - 42
  • [10] Bayesian Population Pharmacokinetic Modeling of Eltrombopag in Chronic Hepatitis C Patients
    Saleh, Mohammad I.
    Melhim, Suhad Bani
    Al-Ramadhani, Hanguin M.
    Alzubiedi, Sameh
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2019, 44 (01) : 31 - 42